Teva Pharmaceutical Industries (NYSE:TEVA) - Page 2

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

Stocks were indicated to open marginally higher again on Thursday, but the Dow Jones industrial average is now up over 2,700 points from its lows seen at the start of ...
Read Full Story »

What Held Back Teva in Q4

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its fourth-quarter financial results before the markets opened on Wednesday. The pharma giant said that it had $0.53 in earnings per share (EPS) ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

The broad markets ended the past week on a negative note, after coming off of an incredible rally in January. Although many companies ended the week with solid gains from ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Stocks had traded lower on Tuesday, but Wednesday's early indications were to recover about half of those prior losses. After so much volatility, investors should be rethinking and considering how ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced on Thursday that it has settled with Amgen Inc. (NASDAQ: AMGN) for its treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The treatment of erectile dysfunction (ED) has helped literally tens of millions of men in America alone. The number of drugs treating ED has grown substantially over the years, and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adamas, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva, Under Armour and More

Stocks were looking for direction on Monday morning ahead of Tuesday's midterms and with new sanctions placed on Iran. While last week's stock market bounce was handily off of the ...
Read Full Story »